| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Zhengcai Zhao CEO | XSHE Exchange | CNE100002CP5 ISIN |
| CN Country | 634 Employees | 22 May 2026 Last Dividend | 10 May 2017 Last Split | - IPO Date |
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD specializes in the research, development, production, and sale of Chinese patent medicines, health food, and Active Pharmaceutical Ingredients (APIs), serving both the domestic market in China and international customers. Established in 2002, the company is headquartered in Lanzhou, China. Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD has built a reputation for its focus on traditional Chinese medicine (TCM) products, leveraging modern scientific methods to ensure the quality and efficacy of its offerings.
This product is designed to address respiratory issues, fashioned to help alleviate coughs and soothe the throat, embodying the principles of traditional Chinese medicine combined with modern pharmaceutical processes.
A targeted remedy for pain relief, these dropping pills are crafted using ancient formulas reputed for their efficacy in relieving pain, demonstrating the company's commitment to blending traditional knowledge with contemporary technical advancements.
These capsules are formulated to enhance vitality and warm the body from within, suited for those suffering from cold limbs and general fatigue, a reflection of the brand's dedication to addressing common health concerns through the wisdom of classical TCM practices.
Another product in their cough care line, these capsules aim to provide relief from persistent coughing, showcasing the company's use of specialized TCM ingredients to target respiratory health issues effectively.
These capsules combine two potent herbs known for their immune-boosting and blood-nourishing properties, designed to promote overall well-being and support the body's natural defenses, highlighting Gansu Longshenrongfa's approach towards holistic health.